Literature DB >> 31677822

Comparative outcomes of right versus left congenital diaphragmatic hernia: A multicenter analysis.

Alexey Abramov1, Weijia Fan2, Rebecca Hernan3, Ariela L Zenilman4, Julia Wynn3, Gudrun Aspelund4, Julie Khlevner3, Usha Krishnan3, Foong-Yen Lim5, George B Mychaliska6, Brad W Warner7, Robert Cusick8, Timothy Crombleholme5, Dai Chung9, Melissa E Danko9, Amy J Wagner10, Kenneth Azarow11, David Schindel12, Douglas Potoka13, Sam Soffer14, Jason Fisher15, David McCulley16, Christiana Farkouh-Karoleski3, Wendy K Chung17, Vincent Duron4.   

Abstract

BACKGROUND: Congenital diaphragmatic hernia (CDH) occurs in 1 out of 2500-3000 live births. Right-sided CDHs (R-CDHs) comprise 25% of all CDH cases, and data are conflicting on outcomes of these patients. The aim of our study was to compare outcomes in patients with right versus left CDH (L-CDH).
METHODS: We analyzed a multicenter prospectively enrolled database to compare baseline characteristics and outcomes of neonates enrolled from January 2005 to January 2019 with R-CDH vs. L-CDH.
RESULTS: A total of 588, 495 L-CDH, and 93 R-CDH patients with CDH were analyzed. L-CDHs were more frequently diagnosed prenatally (p=0.011). Lung-to-head ratio was similar in both cohorts. R-CDHs had a lower frequency of primary repair (p=0.022) and a higher frequency of need for oxygen at discharge (p=0.013). However, in a multivariate analysis, need for oxygen at discharge was no longer significantly different. There were no differences in long-term neurodevelopmental outcomes assessed at two year follow up. There was no difference in mortality, need for ECMO, pulmonary hypertension, or hernia recurrence.
CONCLUSION: In this large series comparing R to L-CDH patients, we found no significant difference in mortality, use of ECMO, or pulmonary complications. Our study supports prior studies that R-CDHs are relatively larger and more often require a patch or muscle flap for repair. TYPE OF STUDY: Prognosis study LEVEL OF EVIDENCE: Level II.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital diaphragmatic hernia; Critical care; ECMO; Thoracic

Mesh:

Year:  2019        PMID: 31677822     DOI: 10.1016/j.jpedsurg.2019.09.046

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

1.  Epithelial cell-adhesion protein cadherin 26 is dysregulated in congenital diaphragmatic hernia and congenital pulmonary airway malformation.

Authors:  Richard Wagner; Henry Li; Lojine Ayoub; Shana Kahnamoui; Daywin Patel; Camelia Stefanovici; Martin Lacher; Richard Keijzer
Journal:  Pediatr Surg Int       Date:  2020-11-08       Impact factor: 1.827

2.  Right Bochdalek congenital diaphragmatic hernia: a tertiary center's experience over 13 years.

Authors:  Alshaima Alghamdi; Enaam Raboe
Journal:  Ann Pediatr Surg       Date:  2021-05-05

Review 3.  Acutely presenting congenital chest lesions: a primer for the radiologist.

Authors:  Apeksha Chaturvedi; Nina Klionsky; Deepa Biyyam; Mitchell A Chess; Nadia Sultan
Journal:  Emerg Radiol       Date:  2022-03-07

4.  Prenatal predictors of mortality in fetuses with congenital diaphragmatic hernia: a systematic review and meta-analysis.

Authors:  Kazunori Masahata; Masaya Yamoto; Satoshi Umeda; Kouji Nagata; Keita Terui; Makoto Fujii; Masayuki Shiraishi; Masahiro Hayakawa; Shoichiro Amari; Kouji Masumoto; Tadaharu Okazaki; Noboru Inamura; Katsuaki Toyoshima; Yuki Koike; Taizo Furukawa; Yuta Yazaki; Akiko Yokoi; Masayuki Endo; Yuko Tazuke; Hiroomi Okuyama; Noriaki Usui
Journal:  Pediatr Surg Int       Date:  2022-09-14       Impact factor: 2.003

5.  Long-Term Outcomes of Congenital Diaphragmatic Hernia: Report of a Multicenter Study in Japan.

Authors:  Masaya Yamoto; Kouji Nagata; Keita Terui; Masahiro Hayakawa; Hiroomi Okuyama; Shoichiro Amari; Akiko Yokoi; Kouji Masumoto; Tadaharu Okazaki; Noboru Inamura; Katsuaki Toyoshima; Yuhki Koike; Yuta Yazaki; Taizo Furukawa; Noriaki Usui
Journal:  Children (Basel)       Date:  2022-06-08

6.  The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer.

Authors:  Andrew Wardley; Javier Cortes; Louise Provencher; Kathy Miller; A Jo Chien; Hope S Rugo; Joyce Steinberg; Jennifer Sugg; Iulia C Tudor; Manon Huizing; Robyn Young; Vandana Abramson; Ron Bose; Lowell Hart; Stephen Chan; David Cameron; Gail S Wright; Marie-Pascale Graas; Patrick Neven; Andrea Rocca; Stefania Russo; Ian E Krop
Journal:  Breast Cancer Res Treat       Date:  2021-02-16       Impact factor: 4.872

7.  Recurrence of Congenital Diaphragmatic Hernia: Risk Factors, Management, and Future Perspectives.

Authors:  Francesco Macchini; Genny Raffaeli; Ilaria Amodeo; Martina Ichino; José Luis Encinas; Leopoldo Martinez; Lucas Wessel; Giacomo Cavallaro
Journal:  Front Pediatr       Date:  2022-02-09       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.